New Drug for Treatment of Parkinson’s Disease Introduced in India
The drug Apomorphine has been launched in India for the first time to treat Parkinson patients.
A private hospital in Bengaluru, has launched Apomorphine for the first time in India, in association with Britannia Pharmaceuticals, a UK-based pharmaceutical company.
The drug has helped in the treatment of Parkinson’s in other countries and now, there is hope for Indians suffering from the disease.
It is available as both injections and infusion pumps, and can provide relief within minutes.
As reported in The New Indian Express, Dr Prashant LK, Parkinson’s Disease and Movement Disorders Specialist at Vikram Hospital, explained that currently in India, patients of Parkinson’s have only two options: either oral treatment for the early stages of the disease, or very expensive Deep Brain Stimulation (DBS) surgery for advanced stages.
There was no treatment for the middle stages of the disease. Moreover, most patients in India couldn’t afford DBS.
Introduction of apomorphine in India has given an important medical option to doctors in the middle stages of the management of Parkinson’s Disease.Dr Prashant LK
The drug will distributed in the country by Vikram Hospitals and then made available in selected centres across the country after the approval of the Drug Controller General of India
Parkinson’s is a neurological disorder that is mainly characterized by problems with body movements, although other symptoms may also occur.
It is estimated that about 30 million people in India suffer from various forms of neurological diseases.
(Subscribe to FIT on Telegram)
Subscribe To Our Daily Newsletter Now.